How does Arcus Biosciences Inc (RCUS) change from a tortoise to a hare?

With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.88 million shares. The 52-week range on RCUS shows that it touched its highest point at $25.47 and its lowest point at $12.95 during that stretch. It currently has a 1-year price target of $38.67. Beta for the stock currently stands at 0.80.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RCUS was up-trending over the past week, with a rise of 12.48%, but this was down by -3.40% over a month. Three-month performance dropped to -5.86% while six-month performance rose 2.33%. The stock gained 2.38% in the past year, while it has lost -3.25% so far this year. A look at the trailing 12-month EPS for RCUS yields -4.15 with Next year EPS estimates of -4.32. For the next quarter, that number is -1.01. This implies an EPS growth rate of 7.42% for this year and -12.49% for next year.

Float and Shares Shorts:

At present, 75.50 million RCUS shares are outstanding with a float of 47.32 million shares on hand for trading. On Mar 15, 2024, short shares totaled 7.98 million, which was 8.79% higher than short shares on Feb 15, 2024. In addition to RCUS as the firm’s Arcus Biosciences, Inc., BCUS serves as its BCUS.

Institutional Ownership:

Through their ownership of 59.80% of RCUS’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RCUS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.